XTX Topco Ltd Has $1.86 Million Position in Encompass Health Co. (NYSE:EHC)

XTX Topco Ltd lifted its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 91.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,193 shares of the company's stock after purchasing an additional 9,191 shares during the quarter. XTX Topco Ltd's holdings in Encompass Health were worth $1,855,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. QRG Capital Management Inc. lifted its position in Encompass Health by 85.6% during the 2nd quarter. QRG Capital Management Inc. now owns 14,365 shares of the company's stock worth $1,232,000 after buying an additional 6,627 shares in the last quarter. SG Americas Securities LLC acquired a new position in Encompass Health during the second quarter valued at approximately $2,204,000. Los Angeles Capital Management LLC grew its stake in Encompass Health by 532.4% in the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company's stock valued at $4,860,000 after purchasing an additional 42,338 shares in the last quarter. Pathstone Holdings LLC increased its position in shares of Encompass Health by 54.5% during the 3rd quarter. Pathstone Holdings LLC now owns 21,022 shares of the company's stock worth $2,032,000 after purchasing an additional 7,412 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C bought a new stake in shares of Encompass Health during the 2nd quarter worth approximately $541,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

EHC has been the topic of several recent analyst reports. UBS Group boosted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Royal Bank of Canada boosted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. Barclays boosted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a report on Tuesday, October 29th. Finally, Truist Financial reaffirmed a "buy" rating and set a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $107.11.

Encompass Health Stock Performance

Shares of EHC traded down $0.37 during midday trading on Friday, reaching $102.50. 536,415 shares of the stock were exchanged, compared to its average volume of 578,782. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock's 50 day simple moving average is $98.85 and its 200 day simple moving average is $92.00. Encompass Health Co. has a twelve month low of $64.15 and a twelve month high of $104.55. The company has a market cap of $10.33 billion, a P/E ratio of 24.76, a PEG ratio of 1.35 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the firm posted $0.86 EPS. The business's revenue for the quarter was up 11.9% compared to the same quarter last year. On average, sell-side analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.